J. Heijman

Isaksen, J. L., Norregaard, M., Manninger, M., Dobrev, D., Jespersen, T., Hermans, B., Heijman, J., Plank, G., Scherr, D., Pock, T., Thambawita, V., Riegler, M. A., Kanters, J. K., & Linz, D. (2025). Evaluating artificial intelligence-enabled medical tests in cardiology: Best practice. IJC Heart and Vasculature, 60, Article 101783. https://doi.org/10.1016/j.ijcha.2025.101783

Fakuade, F. E., Gronwald, J., Brandes, P., Döring, Y., Rubio, T., Seibertz, F., Knierim, M., Abu-Taha, I. H., El-Essawi, A., Jebran, A. F., Danner, B. C., Baraki, H., Kamler, M., Kutschka, I., Heijman, J., Dobrev, D., Schmidt, C., Kallenberger, S. M., & Voigt, N. (2025). Cytosolic calcium handling signature: integration with clinical predictors enhances prediction of post-operative atrial fibrillation. European Heart Journal. Advance online publication. https://doi.org/10.1093/eurheartj/ehaf609

Nimani, S., Bains, S., Alerni, N., Ördög, B., Horváth, A., Matas, L., Louradour, J., Giammarino, L., Tester, D. J., Beslac, O., Lopez, R., Meier, S., Egle, M., Christoforou, N., Barbieri, M., Vashanthakumar, V., Perez-Feliz, S., Parodi, C., Garcia Casalta, L. G., ... Odening, K. E. (2025). AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome. European Heart Journal. Advance online publication. https://doi.org/10.1093/eurheartj/ehaf660

van Cauteren, Y. J. M., Lemmens, M. J. D. K., Bekkers, S. C. A. M., Kietselaer, B. L. J. H., Heijman, J., Theunissen, R. A. L. J., Rahel, B., Voorn, T., van Kuijk, S. M. J., Nijveldt, R., Vernooy, K., Wildberger, J. E., Mihl, C., & Smulders, M. W. (2025). Computed tomography angiography in the diagnosis of non-ST-elevation myocardial infarction: redefining our first line of defense. IJC Heart and Vasculature, 59, Article 101690. https://doi.org/10.1016/j.ijcha.2025.101690

Meier, S., Dobrev, D., Volders, P. G. A., & Heijman, J. (2025). Computational modelling of the pro- and antiarrhythmic effects of atrial high rate-dependent trafficking of small-conductance calcium-activated potassium channels. Journal of Physiology. Advance online publication. https://doi.org/10.1113/JP288659

Cai, M., & Heijman, J. (2025). Challenges and Opportunities for Atrial Fibrillation Management. Cardiology Discovery, 5(2), 149-161. https://doi.org/10.1097/CD9.0000000000000155

Schuijt, E., Scherr, D., Plank, G., Schotten, U., & Heijman, J. (2025). Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation. EP Europace, 27(1), Article euae304. https://doi.org/10.1093/europace/euae304

Cunha, P. S., Laranjo, S., Monteiro, S., Portugal, G., Guerra, C., Rocha, A. C., Pereira, M., Ferreira, R. C., Heijman, J., & Oliveira, M. M. (2024). The impact of atrial voltage and conduction velocity phenotypes on atrial fibrillation recurrence. Frontiers in Cardiovascular Medicine, 11, Article 1427841. https://doi.org/10.3389/fcvm.2024.1427841

Niskala, A., Heijman, J., Dobrev, D., Jespersen, T., & Saljic, A. (2024). Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation. British Journal of Pharmacology, 181(24), 4939-4957. https://doi.org/10.1111/bph.16470